$20.71 -$0.01 (0.0%)

04:30 PM EDT on 05/29/20

Cytokinetics Inc (NASDAQ:CYTK)

CAPS Rating: 4 out of 5

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.

Current Price $20.71 Mkt Cap $1.2B
Open $20.73 P/E Ratio 0.00
Prev. Close $20.72 Div. (Yield) $0.00 (0.0%)
Daily Range $19.67 - $20.79 Volume 1,249,948
52-Wk Range $7.73 - $23.04 Avg. Daily Vol. 956,453

Caps

How do you think NASDAQ:CYTK will perform against the market?

Add Stock to CAPS Watchlist

All Players

158 Outperform
17 Underperform
 

All-Star Players

21 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CYTK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.42)
Submitted August 23, 2013

This is kind of a risky pick, in that I'm betting that the stock will rebound ahead of the presentation of ATOMIC-AHF results at the ESC conference in early September. That doesn't give me a lot of time to escape the pick ahead of data. Thus far.… More

zzlangerhans (99.42)
Submitted July 15, 2013

After being nearly left for dead in 2012, Cytokinetics is enjoying a resurgence on the back of deals with Amgen to expand the omecantiv partnership to Japan and a new deal with Astellas for CK-2127107. The omecantiv deal is especially positive for… More

NASDAQ:CYTK VS S&P 500 (SPY)

Fools bullish on NASDAQ:CYTK are also bullish on:

Fools bearish on NASDAQ:CYTK are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CYTK.

Recs

0
Member Avatar ptanabe (48.21) Submitted: 9/9/2014 1:25:21 PM : Outperform Start Price: $3.67 NASDAQ:CYTK Score: +397.99

ken

Recs

0
Member Avatar OKwarrior (27.78) Submitted: 6/6/2014 1:19:10 AM : Outperform Start Price: $4.88 NASDAQ:CYTK Score: +257.74

It is down, but far from out. I am hoping for a rebound. They do have a cardiac drug remaining in the pipeline that has more than a frozen particulate sphere's chance in Hades

Recs

0
Member Avatar s2dbaker (76.22) Submitted: 1/10/2014 2:14:10 PM : Outperform Start Price: $9.22 NASDAQ:CYTK Score: +53.23

This stock is on the move (hopefully that move is up).

Leaderboard

Find the members with the highest scoring picks in CYTK.

Score Leader

ptanabe

ptanabe (48.21) Score: +397.99

The Score Leader is the player with the highest score across all their picks in CYTK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 71.14 10/13/2014 Outperform 5Y $3.37 +499.70% +60.37% +439.33 0 Comment
ptanabe 48.21 9/9/2014 Outperform 5Y $3.67 +450.31% +52.32% +397.99 1 Comment
flemishinvestor 36.96 11/18/2014 Outperform 3Y $4.21 +380.05% +48.46% +331.59 0 Comment
dflo < 20 12/5/2014 Outperform 5Y $4.57 +342.23% +46.62% +295.62 0 Comment
Playa14 < 20 11/28/2014 11/8/2019 Outperform 5Y $4.58 +341.27% +46.88% +294.38 0 Comment
HongHue < 20 7/6/2012 Outperform 1Y $3.90 +418.21% +124.97% +293.23 0 Comment
Spyrig < 20 12/17/2012 Outperform 5Y $4.02 +402.74% +113.92% +288.82 0 Comment
AsianMatter < 20 4/28/2014 Outperform 3W $4.58 +341.27% +62.94% +278.33 0 Comment
iadops40 52.19 7/13/2012 Outperform 1Y $4.02 +402.74% +127.68% +275.06 0 Comment
mdrnsamurai 24.85 12/12/2012 Outperform 5Y $4.29 +371.10% +111.65% +259.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CYTK.